Category:Statins
class of drugs used to lower cholesterol levels  | |||||
| Upload media | |||||
| Instance of |
| ||||
|---|---|---|---|---|---|
| Subclass of |
| ||||
| Part of |
| ||||
| |||||
 | |||||
Subcategories
This category has only the following subcategory.
H
Pages in category "Statins"
This category contains only the following page.
Media in category "Statins"
The following 44 files are in this category, out of 44 total.
-
Advlip.jpg 911 × 615; 51 KB
-
Algorithm for statin-associated myopathy.jpg 810 × 900; 88 KB
-
Bervastatin.svg 512 × 301; 11 KB
-
Biosynthesis-dielsalder.png 1,523 × 1,602; 77 KB
-
Biosynthesis-lovd.png 1,442 × 1,177; 60 KB
-
Cholesterolbiosynthesis.png 1,930 × 2,427; 40 KB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s2.ogv 20 s, 1,344 × 1,024; 15.49 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s3.ogv 20 s, 1,344 × 1,024; 12.31 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s4.ogv 20 s, 1,344 × 1,024; 10.26 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s5.ogv 19 s, 1,344 × 1,024; 18.75 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s6.ogv 13 s, 1,344 × 1,024; 10.5 MB
-
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s8.ogv 13 s, 1,344 × 1,024; 10.57 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s9.ogv 13 s, 1,344 × 1,024; 8.86 MB
-
Estatina final.png 315 × 209; 13 KB
-
Estatina.png 578 × 174; 17 KB
-
Fluvastatina Grupo fluorofenil.jpg 468 × 311; 26 KB
-
Foto DDD-mit Quelle 2.jpg 4,827 × 4,036; 3.02 MB
-
HMG-CoA reductase pathway.svg 500 × 911; 16 KB
-
Metabolic pathway of a typical statin.png 4,762 × 4,757; 221 KB
-
-
Ogólny mechanizm plejotropowego działania statyn.png 3,507 × 2,480; 403 KB
-
Schematyczna budowa cząsteczki statyn.png 4,877 × 2,170; 109 KB
-
Statin final.svg 210 × 139; 14 KB
-
Statin mechanism v01.svg 652 × 282; 65 KB
-
Statin pharmacophore 2.png 3,787 × 2,861; 63 KB
-
Statin pharmacophore.png 665 × 614; 7 KB
-
Statin pharmacophore.svg 162 × 142; 10 KB
-
Statin Risks (6941350219).jpg 2,784 × 2,702; 1.08 MB
-
Statin-Test.png 838 × 759; 66 KB
-
Statin-use-cardiovascular-disease-death-rate.png 3,400 × 3,844; 1.4 MB
-
Statin-use-vs-share-of-population-with-high-blood-pressure.png 3,400 × 3,865; 1.37 MB
-
Statin.svg 385 × 116; 17 KB
-
Statinfamily.png 1,144 × 315; 48 KB
-
StatinPathway WP430.png 828 × 743; 62 KB
-
Statins-1.generation v01.svg 988 × 476; 103 KB
-
Statins77.png 516 × 461; 38 KB
-
-
Wpływ fluwastatyny na wskaźniki lipidowe 01.png 1,747 × 1,900; 69 KB
-
Wpływ fluwastatyny na wskaźniki lipidowe 02.png 1,747 × 1,891; 46 KB
-
Wpływ fluwastatyny na wskaźniki lipidowe 03.png 1,751 × 1,900; 78 KB
-
Wpływ prawastatyny na wskaźniki lipidowe 01.png 1,747 × 1,900; 75 KB
-
Wpływ prawastatyny na wskaźniki lipidowe 02.png 1,747 × 1,891; 77 KB
-
Wpływ prawastatyny na wskaźniki lipidowe 03.png 1,755 × 1,900; 82 KB
.jpg)
